Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
BMC Cardiovascular Disorders|July 4, 2024
Assessment of adherence to treatment recommendations among patients with heart failure: a cross-sectional studyAleksandra Kukulska, Elżbieta Garwacka-CzachorExpert Opinion on Drug Safety|October 21, 2015
Drug safety evaluation of lenvatinib for thyroid cancerJolanta Krajewska, Aleksandra Kukulska, Barbara JarzabExpert Opinion on Pharmacotherapy|July 12, 2016
Efficacy of lenvatinib in treating thyroid cancerJolanta Krajewska, Aleksandra Kukulska, Barbara JarzabThyroid Research|February 12, 2023
Lobo-isthmectomy in the management of differentiated thyroid cancerJolanta Krajewska, Aleksandra Kukulska, Konrad Samborski, et al.Endocrine Reviews|March 14, 2007
Perspectives and limitations of microarray-based gene expression profiling of thyroid tumorsMarkus Eszlinger, Knut Krohn, Aleksandra Kukulska, et al.Endokrynologia Polska|November 30, 2006
[Hypoparathyroidism after surgery on thyroid cancer: is there a delayed chance for recovery after a prolonged period of substitutive therapy?]Beata Jurecka-Lubieniecka, Ewa Paliczka, Agnieszka Czarniecka, et al.Endokrynologia Polska|November 5, 2010
Treatment with sorafenib in advanced thyroid cancer - a case reportJolanta Krajewska, Tomasz Olczyk, Józef Roskosz, et al.Endokrynologia Polska|December 4, 2025
Real-world study of lenvatinib in patients with radioiodine‑refractory thyroid cancer treated in a tertiary reference centerJolanta Krajewska, Barbara Jarząb, Agata Wilk, et al.Endokrynologia Polska|November 9, 2006
[Expression of selected genes involved in transport of ions in papillary thyroid carcinoma]Monika Gałeza-Kulik, Jadwiga Zebracka, Sylwia Szpak-Ulczok, et al.Frontiers in Endocrinology|October 30, 2020
Early Diagnosis of Low-Risk Papillary Thyroid Cancer Results Rather in Overtreatment Than a Better SurvivalJolanta Krajewska, Aleksandra Kukulska, Malgorzata Oczko-Wojciechowska, et al.Pageof 4